Gufic Biosciences Limited has been given a patent certificate from the Patent Office, The Government of India, for Parenteral Formulations of Levosimendan.

These Stocks were trading close to their 52-week Low as on 2 December 2019.

The zone of 11,970-12,000 would be a crucial support zone. For the bulls to resume its uptrend, it needs to sustain above the identical high of previous two bars, which is placed between 12,137 and 12,147 levels. Stocks in news: Biocon, RBL Bank, IFCI, United Spirits, Aurobindo Pharma, Bank of Baroda.

The weakness of the preceding two trading sessions is likely to exacerbate with the bears tightening their grip as the US President, Donald Trump, said that he plans to reinstate tariffs on metal imports from Brazil and Argentina. This move, most likely, would ruin previous terms with these countries and amplify a global trade war that the president had appeared ready to scale back.

We are ahead of time when it comes to technology. these days, people just search for stuff on the Internet and try to plan their finances. Can online solutions replace the need for having a financial planner? Let’s find out.

While analyzing any company for investment, we are surrounded by many questions, such as what factors to analyze.

As per the survey report, the Nikkei India Manufacturing Purchasing Managers’ Index (PMI), a composite single-figure indicator of manufacturing performance, surged to 51.2 in November from 50.6 in October.

The approved ANDA is a nonsteroidal anti-inflammatory drug, which is used for the treatment of signs and symptoms of osteoarthritis of the knee. Diclofenac Sodium Topical Solution USP, 2 per cent w/w, has an estimated market size of US$974 million for twelve months ending December 2018 according to IQVIA.